Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats

Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes

(2014) Rachel D. Wilson et al.   Pharmacological Reports

The combined effect of metformin and l-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats

(2013) Zenat K. Salman et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications

(2013) Giovanni Targher et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats

(2013) Hiranya Pintana et al.   JOURNAL OF ENDOCRINOLOGY

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

(2013) Martin Haluzík et al.   International Journal of Endocrinology

Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats

(2012) Atul Sureshrao Akarte et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

(2012) Giuseppe Derosa et al.   Current Molecular Pharmacology

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

(2011) J. Shirakawa et al.   DIABETES

Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics

(2011) Natheer H Al-Rawi   Diabetes & Vascular Disease Research

Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice

(2011) Y. Takeda et al.   DIABETOLOGIA

Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886

(2011) Masataka Kusunoki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus

(2011) Tomoyuki Iwasaki et al.   HEPATO-GASTROENTEROLOGY

Treatment of dyslipidemia in patients with type 2 diabetes

(2011) Krishnaswami Vijayaraghavan   Lipids in Health and Disease

Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

(2011) Min Zheng et al.   PLoS One

GLP-1-derived nonapeptide GLP-1(28–36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes

(2011) Eva Tomas et al.   REGULATORY PEPTIDES

Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice

(2010) A. D. Dobrian et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Classificação do diabete melito

(2010) Jorge de Faria Maraschin et al.   Arquivos Brasileiros de Cardiologia

Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor

(2010) Lei Tian et al.   ENDOCRINOLOGY

The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats

(2010) Alokesh Duttaroy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Combination Therapy with Nateglinide and Vildagliptin Improves Postprandial Metabolic Derangements in Zucker Fatty Rats

(2010) K. Miura et al.   HORMONE AND METABOLIC RESEARCH

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus

(2010) Hala O. El-Mesallamy et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Alanine Aminotransferase,  -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis

(2009) A. Fraser et al.   DIABETES CARE

Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers

(2009) Amany A. Abdin et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Current views on type 2 diabetes

(2009) Yi Lin et al.   JOURNAL OF ENDOCRINOLOGY

Serum nitric oxide metabolites in subjects with metabolic syndrome

(2008) Saleh Zahedi Asl et al.   CLINICAL BIOCHEMISTRY

Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes

(2008) Nasser Mikhail   EXPERT OPINION ON INVESTIGATIONAL DRUGS